Peptide-based drug discovery: Current status and recent advances.

Sharma, Komal et al.·Drug discovery today·2023·
RPEP-073722023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Peptide-based drug discovery: Current status and recent advances.
Published In:
Drug discovery today, 28(2), 103464 (2023)
Database ID:
RPEP-07372

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-07372·https://rethinkpeptides.com/research/RPEP-07372

APA

Sharma, Komal; Sharma, Krishna K; Sharma, Anku; Jain, Rahul. (2023). Peptide-based drug discovery: Current status and recent advances.. Drug discovery today, 28(2), 103464. https://doi.org/10.1016/j.drudis.2022.103464

MLA

Sharma, Komal, et al. "Peptide-based drug discovery: Current status and recent advances.." Drug discovery today, 2023. https://doi.org/10.1016/j.drudis.2022.103464

RethinkPeptides

RethinkPeptides Research Database. "Peptide-based drug discovery: Current status and recent adva..." RPEP-07372. Retrieved from https://rethinkpeptides.com/research/sharma-2023-peptidebased-drug-discovery-current

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.